Novavax, Inc. faces declining revenues and high risks despite the Sanofi deal and cost-cutting measures. Click here for my ...

Viking Therapeutics (NASDAQ: VKTX) and Novavax (NASDAQ: NVAX) were two of the big winners in the biotech industry last year.

Stocks recovered on Friday, with all three major indexes in the green, as the tech sector bounced back from Thursday's losses ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors ...

The life sciences industry experienced a dynamic year in 2024. As the public markets gained traction, IPO activity and venture investment saw ...